Historique de carrière de David N. Bell
Anciens postes connus de David N. Bell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Directeur Technique/Scientifique/R&D | 09/07/2007 | 01/01/2020 |
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Directeur Technique/Scientifique/R&D | 03/06/2011 | - |
Formation de David N. Bell
| McGill University | Graduate Degree |
Statistiques
Internationale
| Canada | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
1608557 Ontario, Inc.
1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Health Technology |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
- Bourse
- Insiders
- David N. Bell
- Expérience
